| Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways ET Cirulli, BN Lasseigne, S Petrovski, PC Sapp, PA Dion, CS Leblond, ... Science 347 (6229), 1436-1441, 2015 | 987 | 2015 |
| Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial PH Gordon, DH Moore, RG Miller, JM Florence, JL Verheijde, C Doorish, ... The Lancet Neurology 6 (12), 1045-1053, 2007 | 755 | 2007 |
| Genome-wide analyses identify KIF5A as a novel ALS gene A Nicolas, KP Kenna, AE Renton, N Ticozzi, F Faghri, R Chia, ... Neuron 97 (6), 1268-1283. e6, 2018 | 576 | 2018 |
| Dual-wavelength ratiometric fluorescence measurement of the membrane dipole potential E Gross, RS Bedlack, LM Loew Biophysical journal 67 (1), 208-216, 1994 | 332 | 1994 |
| Localized membrane depolarizations and localized calcium influx during electric field-guided neurite growth RS Bedlack Jr, LM Loew Neuron 9 (3), 393-403, 1992 | 242 | 1992 |
| Pesticide exposure and amyotrophic lateral sclerosis F Kamel, DM Umbach, RS Bedlack, M Richards, M Watson, ... Neurotoxicology 33 (3), 457-462, 2012 | 204 | 2012 |
| Phase 2 study of sodium phenylbutyrate in ALS ME Cudkowicz, PL Andres, SA Macdonald, RS Bedlack, R Choudry, ... Amyotrophic Lateral Sclerosis 10 (2), 99-106, 2009 | 171 | 2009 |
| Quantitative myasthenia gravis score: assessment of responsiveness and longitudinal validity RS Bedlack, DL Simel, H Bosworth, G Samsa, B Tucker-Lipscomb, ... Neurology 64 (11), 1968-1970, 2005 | 152 | 2005 |
| Does this patient have myasthenia gravis? K Scherer, RS Bedlack, DL Simel Jama 293 (15), 1906-1914, 2005 | 140 | 2005 |
| Independent home use of a brain-computer interface by people with amyotrophic lateral sclerosis JR Wolpaw, RS Bedlack, DJ Reda, RJ Ringer, PG Banks, TM Vaughan, ... Neurology 91 (3), e258-e267, 2018 | 139 | 2018 |
| Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS J Rosenfeld, RM King, CE Jackson, RS Bedlack, RJ Barohn, A Dick, ... Amyotrophic Lateral Sclerosis 9 (5), 266-272, 2008 | 121 | 2008 |
| Apolipoprotein E and neuromuscular disease: a critical review of the literature RS Bedlack, WJ Strittmatter, JC Morgenlander Archives of neurology 57 (11), 1561-1565, 2000 | 101 | 2000 |
| Cognitive-behavioral screening reveals prevalent impairment in a large multicenter ALS cohort J Murphy, P Factor-Litvak, R Goetz, C Lomen-Hoerth, PL Nagy, J Hupf, ... Neurology 86 (9), 813-820, 2016 | 100 | 2016 |
| Randomized phase 2 trial of NP001, a novel immune regulator: Safety and early efficacy in ALS RG Miller, G Block, JS Katz, RJ Barohn, V Gopalakrishnan, M Cudkowicz, ... Neuroimmunology & Neuroinflammation 2 (3), e100, 2015 | 100 | 2015 |
| Effect of ezogabine on cortical and spinal motor neuron excitability in amyotrophic lateral sclerosis: a randomized clinical trial BJ Wainger, EA Macklin, S Vucic, CE McIlduff, S Paganoni, NJ Maragakis, ... JAMA neurology 78 (2), 186-196, 2021 | 95 | 2021 |
| How common are ALS plateaus and reversals? RS Bedlack, T Vaughan, P Wicks, J Heywood, E Sinani, R Selsov, ... Neurology 86 (9), 808-812, 2016 | 93 | 2016 |
| On the concept of myasthenic crisis RS Bedlack, DB Sanders Journal of clinical neuromuscular disease 4 (1), 40-42, 2002 | 93 | 2002 |
| MNGIE neuropathy: five cases mimicking chronic inflammatory demyelinating polyneuropathy RS Bedlack, T Vu, S Hammans, SA Sparr, B Myers, J Morgenlander, ... Muscle & nerve 29 (3), 364-368, 2004 | 91 | 2004 |
| Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis S Paganoni, C Karam, N Joyce, R Bedlack, GT Carter NeuroRehabilitation 37 (1), 53-68, 2015 | 89 | 2015 |
| Palliative care issues in amyotrophic lateral sclerosis: an evidenced-based review CY Karam, S Paganoni, N Joyce, GT Carter, R Bedlack American Journal of Hospice and Palliative Medicine® 33 (1), 84-92, 2016 | 84 | 2016 |
